Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 20Carcinoma, Non-Small-Cell Lung 20Uterine Cervical Neoplasms 15Oropharyngeal Neoplasms 14Lung Neoplasms 14Mouth Neoplasms 10Laryngeal Neoplasms 10Carcinoma 10Urinary Bladder Neoplasms 8Hypopharyngeal Neoplasms 8Cholangiocarcinoma 8Pancreatic Neoplasms 7Ovarian Neoplasms 7Nasopharyngeal Carcinoma 6Mesothelioma, Malignant 6Medulloblastoma 6Gallbladder Neoplasms 6Neuroblastoma 5Ganglioneuroblastoma 5Fallopian Tube Neoplasms 5Lymphoid Interstitial Pneumonia 4Vulvar Neoplasms 3Urethral Neoplasms 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Carcinoma, Transitional Cell 3Brenner Tumor 3Adenocarcinoma of Lung 3Vaginal Neoplasms 2

Interventions

Cisplatin 6Pemetrexed 5cediranib 3Chemotherapy, Adjuvant 3Radiotherapy 2Neoadjuvant Therapy 2Gemcitabine 2vatalanib 1rilotumumab 1pembrolizumab 1belinostat 1Watchful Waiting 1Vinorelbine 1Talc 1Sorafenib 1Semaxinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Platinum 1Pharmacogenomic Testing 1Methotrexate 1Immunoenzyme Techniques 1Gefitinib 1Erlotinib Hydrochloride 1Dihematoporphyrin Ether 1Dasatinib 1Capecitabine 1Bevacizumab 1ARQ 197 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solitary Fibrous Tumor, Pleural × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
117 enrolled 23 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡